openPR Logo
Press release

Sequenom to Lead in the NIPD Market

09-12-2012 03:47 PM CET | Health & Medicine

Press release from: RNCOS E-Services Pvt. Ltd.

/ PR Agency: RNCOS E-Services Pvt. Ltd.
Sequenom is expected to remain the undefeated market leader in the US NIPD market, says RNCOS.

Sequenom is expected to remain the undefeated market leader in the US NIPD market, says RNCOS.

According to a new research report by RNCOS entitled, “US Non-Invasive Prenatal Diagnostics - Market Insight”, Sequenom is expected to remain the undefeated market leader in the US NIPD market. Sequenom markets its MaterniT21 test in the NIPD market that analyzes circulating cell-free DNA extracted from a maternal blood sample utilizing massively parallel sequencing. The product was amongst the first NIPD tests available and has presented Sequenom with an undefeated market presence. With growing demands for such non-invasive tests, Sequenom is expected to continue to be the market leader in the NIPD segment in the future as well.

The US Non-invasive prenatal diagnostic market is a relatively new sector in the diagnostics industry. Currently, the NIPD market is represented by only a few companies such as Sequenom, Verinata and Ariosa diagnostics. One of the promising new market entrants is Natera. The sector has a highly untapped potential and is expected that it will evolve greatly in the future. Research and innovation in the sector is very robust and there are several clinical trials being undergone at present. Regulatory intervention is weak as NIPD tests are classified as Lab Developed Tests (LDTs) that do not require FDA regulation. According to a latest report by RNCOS, “US Non-Invasive Prenatal Diagnostics - Market Insight”, the US NIPD market is expected to show a double-digit growth from 2012-2016.

The report spread in over 55 pages provides an in-depth research and rational analysis of the current status and expected position of the US NIPD Market. It facilitates the future forecasts on the overall US NIPD Market size by 2016 and takes into account pessimistic and optimistic scenarios that could prevail in the market. Moreover, it also projects the potential market to be tapped by currently active market players. Opportunity assessment for companies in the US NIPD Market in terms of leading technologies is also analyzed in the report. In addition, the report elaborates on the ongoing clinical trials and the various restraints faced by the sector. To provide a holistic view, it also provides a competitive assessment of the major players describing their key business and comparing their strengths and weaknesses.

For FREE SAMPLE of this report visit: http://www.rncos.com/Report/IM450.htm

Some of our Related Reports are:

- US Cardiac Device Market Analysis (http://www.rncos.com/Report/IM441.htm)
- US Clinical Laboratory Testing Market Assessment (http://www.rncos.com/Report/IM442.htm)
- Global Genetic Testing Market Forecast to 2015 (http://www.rncos.com/Report/IM445.htm)
- Indian Diagnostic Services Market Outlook 2015 (http://www.rncos.com/Report/IM418.htm)
- US Nutraceuticals Market Analysis (http://www.rncos.com/Report/IM350.htm)

Check Related REPORTS on: http://www.rncos.com/Healthcare_Industry.htm

About RNCOS

RNCOS specializes in Industry intelligence and creative solutions for contemporary business segments. Our professionals analyze the industry and its various components, with a comprehensive study of the changing market behavior. Our accuracy and data precision proves beneficial in terms of pricing and time management that assist the intending consultants in meeting their objectives in a cost-effective and timely manner.

B-129, Sector 6 Noida - 201301
91-120-4224-700
91-120-4224-707

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Sequenom to Lead in the NIPD Market here

News-ID: 234772 • Views:

More Releases from RNCOS E-Services Pvt. Ltd.

Malaysia Convenience Store Witnessing Tremendous Growth
Malaysia Convenience Store Witnessing Tremendous Growth
“Rapid expansion plans of major convenience stores in Malaysia such as 7-Eleve and 99 Speed Mart are expected to drive the market.” says RNCOS Malaysia Convenience store has been witnessing a tremendous growth in the retail industry. Key players in the country are widening their foot prints in retail industry by innovatively increasing the product portfolio as per the consumer behavior and increasing the number of stores. There is a cut
Growing Opportunity in the Global Enterprise Software Market
Growing Opportunity in the Global Enterprise Software Market
“Increasing adoption of enterprise resource management software, customer relationship management software and human resource management software is expected to drive the Global Enterprise Software market.” Says RNCOS The global enterprise software market has reported a significant growth in the recent years and is presenting ample opportunities to the industry’s players. With increasing global competition and rising awareness regarding enterprises software across the globe, the worldwide enterprise software market is poised to

More Releases for NIPD

Factors Influencing Global Cell-free DNA (cfDNA) Testing Market through 2022 and …
Global Cell-free DNA (cfDNA) Testing Market report emphasizes the detailed understanding of some decisive factors such as size, share, sales, forecast trends, supply, production, demands, industry, and CAGR in order to provide a comprehensive outlook of the global market. Additionally, the report also highlights the challenges impeding market growth and expansion strategies employed by leading companies in the "Cell-free DNA (cfDNA) Testing Market". Global Cell-free DNA (cfDNA) Testing Market research report
Europe Non–Invasive Prenatal Testing Market Demand and Key Players by 2025 -: …
"The study of the Europe Non–Invasive Prenatal Testing Market by Stats and Reports provides the market size information and market trends along with factors and parameters impacting it in both short- and long-term. The study provides a 360 view and insights, outlining the key outcomes of the industry. These insights help the business decision-makers to formulate better business plans and make informed decisions for improved profitability. In addition, the study
Europe Non Invasive Prenatal Testing Market to by 2025 With Key Companies Ariosa …
Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025.The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods.“Europe Non–Invasive Prenatal Testing
Europe Non–Invasive Prenatal Testing Market Forecast 2018-2025 - Ariosa Diagno …
A report added to the rich database of Qurate Business Intelligence, titled “Global Non–Invasive Prenatal Testing Industry, 2018 Market Research Report”, provides a 360-degree overview of the worldwide market. Approximations associated with the market values over the forecast period are based on empirical research and data collected through both primary and secondary sources. The authentic processes followed to exhibit various aspects of the market makes the data reliable in context
Europe Non Invasive Prenatal Testing Market 2018-Top key players Ariosa Diagnost …
Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025.The market is driven by number of factors such as high incidence rate of babies born with down syndrome, no risk of miscarriage with NIPT test, shifting trend towards child bearing at advanced maternal age (35 years or older), rising focus on reimbursement for NIPT and increasing preference for non–invasive techniques over invasive methods. Request for Sample @
Europe Non–Invasive Prenatal Testing Market by 2025 with Key Players Ariosa Di …
Europe Non–Invasive Prenatal Testing market is set to touch US$ 500 Million by 2025. “Europe Non–Invasive Prenatal Testing Market Research Report 2018” presents an in–depth assessment of the Europe non–invasive prenatal testing market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the most up–to–date industry data on the market situation and future outlook. The research includes historic data from 2014 to 2017 and forecasts until 2025. Get